Anti-IGFBP7 antibody (194-207) (STJ71556)

SKU:
STJ71556-100

Shipping:
Free Shipping
Current Stock:
Host: Goat
Applications: Pep-ELISA/IHC
Reactivity: Human/Cow
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Goat polyclonal antibody anti-IGFBP7 (194-207) is suitable for use in ELISA and Immunohistochemistry research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA
Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Concentration: 0.5 mg/mL
Dilution Range: IHC-2.5µg/ml
ELISA-antibody detection limit dilution 1:16000.
Storage Instruction: Store at-20°C on receipt and minimise freeze-thaw cycles.
Gene Symbol: IGFBP7
Gene ID: 3490
Uniprot ID: IBP7_HUMAN
Immunogen Region: 194-207
Accession Number: NP_001544.1
Immunogen Sequence: NKVKRGHYGVQRTE
Function Binds IGF-I and IGF-II with a relatively low affinity. Stimulates prostacyclin (PGI2) production. Stimulates cell adhesion.
Protein Name Insulin-Like Growth Factor-Binding Protein 7
Ibp-7
Igf-Binding Protein 7
Igfbp-7
Igfbp-Rp1
Mac25 Protein
Pgi2-Stimulating Factor
Prostacyclin-Stimulating Factor
Tumor-Derived Adhesion Factor
Taf
Database Links Reactome: R-HSA-2559582
Reactome: R-HSA-381426
Reactome: R-HSA-8957275
Cellular Localisation Secreted
Alternative Antibody Names Anti-Insulin-Like Growth Factor-Binding Protein 7 antibody
Anti-Ibp-7 antibody
Anti-Igf-Binding Protein 7 antibody
Anti-Igfbp-7 antibody
Anti-Igfbp-Rp1 antibody
Anti-Mac25 Protein antibody
Anti-Pgi2-Stimulating Factor antibody
Anti-Prostacyclin-Stimulating Factor antibody
Anti-Tumor-Derived Adhesion Factor antibody
Anti-Taf antibody
Anti-IGFBP7 antibody
Anti-MAC25 antibody
Anti-PSF antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance